 Vamsi Guntur
Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 6 | 2022 | 2029 | 0.790 |
Why?
| | Granulomatosis with Polyangiitis | 2 | 2021 | 41 | 0.740 |
Why?
| | Churg-Strauss Syndrome | 1 | 2020 | 17 | 0.710 |
Why?
| | Nicotinic Agonists | 1 | 2014 | 100 | 0.420 |
Why?
| | Airway Resistance | 2 | 2013 | 29 | 0.390 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2012 | 395 | 0.390 |
Why?
| | Airway Remodeling | 1 | 2012 | 57 | 0.390 |
Why?
| | Nicotine | 1 | 2014 | 265 | 0.380 |
Why?
| | Drug Delivery Systems | 2 | 2010 | 296 | 0.370 |
Why?
| | Expectorants | 1 | 2010 | 24 | 0.360 |
Why?
| | Smoking Cessation | 1 | 2014 | 374 | 0.350 |
Why?
| | Nebulizers and Vaporizers | 3 | 2013 | 78 | 0.340 |
Why?
| | Acetylcysteine | 1 | 2010 | 141 | 0.340 |
Why?
| | Protein Kinase Inhibitors | 2 | 2012 | 785 | 0.330 |
Why?
| | Respiratory Therapy | 1 | 2007 | 19 | 0.290 |
Why?
| | Smoking | 1 | 2014 | 1381 | 0.280 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2010 | 445 | 0.270 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2021 | 663 | 0.270 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2010 | 636 | 0.260 |
Why?
| | Respiration, Artificial | 1 | 2008 | 529 | 0.230 |
Why?
| | Anti-Asthmatic Agents | 2 | 2021 | 349 | 0.220 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 961 | 0.200 |
Why?
| | Mucociliary Clearance | 1 | 2022 | 41 | 0.190 |
Why?
| | Interleukin-5 | 1 | 2021 | 30 | 0.180 |
Why?
| | Eosinophilia | 2 | 2021 | 186 | 0.180 |
Why?
| | Fever | 1 | 2022 | 280 | 0.180 |
Why?
| | Aerosols | 3 | 2010 | 150 | 0.180 |
Why?
| | Bronchoscopy | 1 | 2022 | 245 | 0.170 |
Why?
| | Steroids | 1 | 2020 | 144 | 0.170 |
Why?
| | Antineoplastic Agents | 1 | 2010 | 1879 | 0.170 |
Why?
| | Lung | 3 | 2022 | 3559 | 0.160 |
Why?
| | Lung Neoplasms | 1 | 2010 | 2177 | 0.150 |
Why?
| | Insulin | 1 | 2007 | 2078 | 0.150 |
Why?
| | Referral and Consultation | 1 | 2022 | 632 | 0.140 |
Why?
| | Cats | 3 | 2013 | 193 | 0.140 |
Why?
| | Pilot Projects | 1 | 2020 | 1373 | 0.130 |
Why?
| | Humans | 10 | 2022 | 114662 | 0.120 |
Why?
| | Equipment and Supplies | 1 | 2014 | 38 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2007 | 2094 | 0.110 |
Why?
| | Inflammation | 2 | 2022 | 2478 | 0.110 |
Why?
| | Cat Diseases | 1 | 2013 | 13 | 0.110 |
Why?
| | Lidocaine | 1 | 2013 | 40 | 0.100 |
Why?
| | Cisplatin | 2 | 2010 | 262 | 0.100 |
Why?
| | Anesthetics, Local | 1 | 2013 | 81 | 0.100 |
Why?
| | Biomarkers | 1 | 2022 | 3408 | 0.100 |
Why?
| | Perception | 1 | 2014 | 311 | 0.100 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2007 | 3252 | 0.090 |
Why?
| | Bronchoconstriction | 1 | 2010 | 26 | 0.090 |
Why?
| | Paclitaxel | 1 | 2010 | 190 | 0.080 |
Why?
| | Prospective Studies | 1 | 2020 | 6219 | 0.080 |
Why?
| | Intubation, Intratracheal | 1 | 2010 | 216 | 0.080 |
Why?
| | Transfection | 1 | 2010 | 866 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 797 | 0.080 |
Why?
| | Male | 6 | 2022 | 55583 | 0.070 |
Why?
| | Blotting, Western | 1 | 2010 | 1147 | 0.070 |
Why?
| | Cell Survival | 1 | 2010 | 1021 | 0.070 |
Why?
| | Antioxidants | 1 | 2010 | 530 | 0.070 |
Why?
| | Adult | 3 | 2022 | 30544 | 0.070 |
Why?
| | Retrospective Studies | 1 | 2022 | 12546 | 0.060 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 2710 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2021 | 9088 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1355 | 0.050 |
Why?
| | Cynodon | 2 | 2013 | 2 | 0.050 |
Why?
| | Methacholine Chloride | 2 | 2013 | 47 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2010 | 3532 | 0.050 |
Why?
| | Gonadal Steroid Hormones | 1 | 2021 | 124 | 0.040 |
Why?
| | Prednisone | 1 | 2021 | 229 | 0.040 |
Why?
| | Signal Transduction | 1 | 2012 | 4512 | 0.040 |
Why?
| | Allergens | 2 | 2013 | 413 | 0.040 |
Why?
| | Animals | 4 | 2013 | 31699 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2021 | 497 | 0.040 |
Why?
| | Female | 4 | 2021 | 59493 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 1715 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2251 | 0.030 |
Why?
| | Bronchoconstrictor Agents | 1 | 2013 | 14 | 0.030 |
Why?
| | Thiazoles | 1 | 2012 | 110 | 0.020 |
Why?
| | Benzamides | 1 | 2012 | 169 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2013 | 440 | 0.020 |
Why?
| | United States | 1 | 2007 | 12181 | 0.020 |
Why?
| | Piperidines | 1 | 2012 | 160 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2012 | 314 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2010 | 286 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 5518 | 0.020 |
Why?
| | Catheterization | 1 | 2010 | 159 | 0.020 |
Why?
| | Eosinophils | 1 | 2012 | 278 | 0.020 |
Why?
| | Deoxycytidine | 1 | 2010 | 138 | 0.020 |
Why?
| | Dogs | 1 | 2010 | 334 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 590 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2010 | 641 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 425 | 0.020 |
Why?
| | Radiography | 1 | 2010 | 812 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 1842 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1578 | 0.020 |
Why?
| | Child | 1 | 2021 | 18412 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 26733 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6115 | 0.010 |
Why?
|
|
Guntur's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|